Mayo Clinic Riyadh office raises referral question for 12,386 UAE providers

Mayo Clinic has opened a Riyadh patient information office to help Saudi patients reach its campuses in the US and London, a move that gives UAE hospitals, clinics and insurers a sharper benchmark for complex-case referrals.

The highest-stakes readers are CEOs, CFOs and COOs. For Dubai operators licensed by the Dubai Health Authority (DHA), the question is whether more Gulf patients expect a formal concierge pathway for rare, undiagnosed or high-acuity cases before they commit to local tertiary care. For Abu Dhabi providers regulated by the Department of Health Abu Dhabi (DOH), the comparison is direct because Mayo has already worked in the emirate through Sheikh Shakhbout Medical City. For northern emirates providers regulated by the Ministry of Health and Prevention (MOHAP), the lesson is referral coordination rather than brand scale.

What Mayo is offering in Riyadh

Gulf Business reported on 2 September 2026 that the Riyadh office helps patients with appointments, medical records, scheduling, travel, lodging, billing, insurance questions and follow-up after return. It does not provide treatment.

"The Riyadh office is not a clinical facility, and it does not provide medical care." Dr Omar Ghanem, Mayo Clinic medical director for the Middle East, told Gulf Business.

Patients can seek appointments at Rochester, Minnesota, Phoenix and Scottsdale, Arizona, Jacksonville, Florida, and Mayo Clinic Healthcare in London, according to the same interview. Mayo's international appointment guidance says its International Patient Center contacts patients 1 to 2 weeks before arrival to review schedules, and Mayo can provide a visa support letter when needed.

Why UAE operators should care

Dubai already sells itself as a medical travel hub. DHA data reported by WAM showed more than 691,000 international health tourists in 2023, with direct healthcare spending above AED 1.03 billion. That market is exposed when a global academic brand makes the overseas pathway easier for GCC families.

The practical risk is leakage in the high-margin end of care: oncology, transplant assessment, complex orthopaedics, neurology and rare disease workups. UAE providers should not assume every patient wants to leave the region. Many want a credible diagnosis, a written plan and a named route back into local follow-up. That is an operational product, not a marketing line.

• Dubai clinics should document referral response times, records-transfer procedures and second-opinion workflows under DHA-licensed operations.
• Abu Dhabi hospitals should compare complex-care pathways against DOH requirements and their own insurer authorisation timelines.
• Northern emirates providers should verify MOHAP licence status, specialist availability and medical-record export processes before promising cross-border coordination.
• Insurers should require case estimates, pre-authorisation evidence and a local follow-up plan before approving overseas treatment.

Costs, cover and the UAE patient decision

Mayo does not publish a standard price list for international complex care. Its international billing guidance says costs depend on medical need and insurance coverage, and that international account representatives can provide price estimates, deposit requirements and payment options. Formal estimates for international patients can be requested through +1-507-284-5063, according to Mayo's price-estimate page.

For UAE patients, the finance question starts before the aircraft booking. Daman, Thiqa and Sukoon members should check whether their specific policy covers planned overseas care, second opinions or only emergency treatment abroad. Coverage can differ by employer plan, network tier and pre-authorisation status. The insurer's written approval should name the provider, country, treatment episode, validity period and reimbursement basis.

For UAE providers, the response should be concrete. Build a one-page complex-case pathway that states who reviews the file, which specialties are available locally, when an overseas opinion is appropriate, and how records return into the UAE chart. CIOs should check whether imaging, pathology, discharge summaries and medication lists can be exported in usable formats within 48 to 72 hours after consent. COOs should measure how often complex-case patients leave the system after first consultation.

Mayo's Riyadh office is a signal that cross-border care is becoming more organised for Gulf patients. UAE hospitals do not need to copy the model in full. They do need visible second-opinion access, fast records handling and clear insurer documentation. Patients comparing local options can start with the UAE Open Healthcare Directory, which lists 12,386+ licensed providers across 8 UAE cities and 26 specialties.